MENU
SUPN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Supernus Pharmaceuticals (SUPN) Earnings Date & Reports

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company... Show more

A.I. Advisor
published Earnings

SUPN is expected to report earnings to fall 27.30% to 43 cents per share on August 11

Supernus Pharmaceuticals SUPN Stock Earnings Reports
Q2'26
Est.
$0.44
Q1'26
Beat
by $0.41
Q4'25
Missed
by $0.48
Q3'25
Missed
by $0.94
Q2'25
Missed
by $0.08
The last earnings report on May 05 showed earnings per share of 60 cents, beating the estimate of 19 cents. With 3.34M shares outstanding, the current market capitalization sits at 2.72B.
View a ticker or compare two or three
SUPN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer for the treatment of central nervous system

Industry PharmaceuticalsGeneric

Profile
Details
Industry
Pharmaceuticals Other
Address
9715 Key West Avenue
Phone
+1 301 838-2500
Employees
778
Web
https://www.supernus.com